Analysen von Florent Cespedes
23.03.17 | Roche buy | Société Générale Group S.A. (SG) | |
23.03.17 | Sanofi buy | Société Générale Group S.A. (SG) | |
08.03.17 | Novartis buy | Société Générale Group S.A. (SG) | |
31.10.16 | Sanofi buy | Société Générale Group S.A. (SG) | |
01.08.16 | Sanofi buy | Société Générale Group S.A. (SG) | |
06.04.16 | Sanofi buy | Société Générale Group S.A. (SG) | |
10.02.16 | Sanofi buy | Société Générale Group S.A. (SG) | |
09.11.15 | Sanofi buy | Société Générale Group S.A. (SG) | |
Werbung
|
|||
30.10.15 | Sanofi buy | Société Générale Group S.A. (SG) | |
03.07.15 | Sanofi buy | Société Générale Group S.A. (SG) | |
16.04.15 | Sanofi buy | Société Générale Group S.A. (SG) | |
19.09.14 | Bayer Outperform | BNP PARIBAS | |
04.09.14 | Sanofi Outperform | BNP PARIBAS | |
04.09.14 | Novartis Outperform | BNP PARIBAS | |
01.08.14 | Sanofi Outperform | BNP PARIBAS | |
27.05.14 | Novartis Outperform | BNP PARIBAS | |
02.05.14 | Bayer Outperform | BNP PARIBAS | |
17.03.14 | Bayer Outperform | BNP PARIBAS | |
24.08.12 | GSK outperform | Exane-BNP Paribas SA | |
03.08.12 | Teva Pharmaceutical Industries outperform | Exane-BNP Paribas SA | |
02.08.12 | Shire outperform | Exane-BNP Paribas SA | |
27.07.12 | Sanofi outperform | Exane-BNP Paribas SA | |
27.07.12 | Roche outperform | Exane-BNP Paribas SA | |
26.07.12 | GSK outperform | Exane-BNP Paribas SA | |
19.07.12 | GSK outperform | Exane-BNP Paribas SA | |
18.07.12 | Shire outperform | Exane-BNP Paribas SA | |
16.07.12 | Actelion outperform | Exane-BNP Paribas SA | |
26.06.12 | Teva Pharmaceutical Industries outperform | Exane-BNP Paribas SA | |
26.06.12 | Shire outperform | Exane-BNP Paribas SA | |
19.06.12 | GSK outperform | Exane-BNP Paribas SA | |
04.05.12 | Teva Pharmaceutical Industries outperform | Exane-BNP Paribas SA | |
30.04.12 | Sanofi outperform | Exane-BNP Paribas SA | |
24.04.12 | Sanofi outperform | Exane-BNP Paribas SA | |
02.04.12 | GSK outperform | Exane-BNP Paribas SA | |
16.03.12 | Roche outperform | Exane-BNP Paribas SA | |
03.09.10 | Bayer outperform | Exane-BNP Paribas SA |